TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Glenview Doubles Down on Teva Stock With $72 Million Buy, According to Recent SEC Filing

The Motley Fool Logo The Motley Fool By Jake Lerch
Glenview Doubles Down on Teva Stock With $72 Million Buy, According to Recent SEC Filing

Glenview Capital Management increased its stake in Teva Pharmaceutical Industries by 868,457 shares in Q3 2025, adding approximately $72 million in value. The investment now represents 7.51% of the fund's assets under management and is its 4th-largest holding.

Insights
CADE   neutral

Proposed sale to Huntington Bancshares with stock conversion ratio of 2.475 shares


TEVA   positive

Stock has performed well (up 157% over five years), Glenview is increasing its position, indicating strong confidence in the company's potential